CDSCO

Zydus begins Phase II trial of ZYIL1, NLRP3 inhibitor in patients with ALS

Read more

IPA organises eighth Advanced GMP Workshop

Read more

India Pharma Inc in M&A mode once again

Read more

CDSCO and IDMA organise ‘Revision of Schedule-M’ workshop in Mumbai

Read more

CDSCO to conduct awareness workshops on ‘Revision of Schedule M’

Read more

Cracking the code – Generic vs. Brand Medicines

Read more

143 pharma companies get show cause notices from CDSCO post inspections

Read more

Centhaquine set to enter US-FDA approved Phase 3 clinical trial in US and Europe

Read more

In search of consistent quality

Read more

AstraZeneca gets CDSCO approval for Tremelimumab combination in India

Read more